spacer
home > ict > summer 2019 > therapeutic oncology and the road ahead
PUBLICATIONS
International Clinical Trials

Therapeutic Oncology and the Road Ahead




ICT: What trends are you seeing in therapeutic oncology?

Dr Tim Williams: We are seeing significant interest in the application of remote, digital patient-reported outcomes measurement (PROMs) to enhance routine cancer care in the UK. There is growing awareness of the importance in quality of life as more people live with and beyond cancer, as well as a drive for new approaches to support cancer service delivery and better care for patients over the long term, focusing on acute treatment at a time when the workforce faces increased pressure.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
About the author


Dr Tim Williams is the Co-Founder and CEO of My Clinical Outcomes (MCO), a clinical technology platform that automates the collection and analysis of PROMs in routine clinical practice. Tim previously worked as an NHS doctor and Strategy Consultant and has a keen interest in how technology can help improve healthcare services. MCO is in use at over 70 UK public and private hospitals in a range of conditions and specialties and is now working on several innovative projects helping to support the care of cancer patients in the NHS.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo keeps growing in the first quarter of 2019

Maintaining its accomplished operations from Ataturk and Istanbul airports as "Dual Hub", the global brand of Turkish Cargo continued its strong growth momentum during the first quarter of the year despite the shrinkage of the global air cargo sector.
More info >>

White Papers

eSource: Reducing Site Workload for Better, Faster, Safer Clinical Trials

Clinical Ink

Unlike traditional electronic data capture (EDC), SureSource, Clinical Ink’s eSource platform, was designed from the beginning to minimize clinical trial complexity for site users. A Site Impact Survey provides scientific evidence regarding the impact of SureSource from 517 site users. Results confirm it significantly reduces workload, lessens queries, and improves data quality compared to paper and EDC. In this white paper, we quantitatively evaluate survey outcomes, provide qualitative feedback from survey respondents, and highlight the observed benefits of SureSource for transforming clinical research.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement